Nrc Health Quick Ratio (NRC) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Nrc Health  (NASDAQ: NRC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Nrc Health's Quick Ratio

NRC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.09 below Nrc Health average.

Within Medical Laboratories industry 30 other companies have achieved higher Quick Ratio than Nrc Health in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 3294 to 3695.

Explain Quick Ratio?
How much Cash & cash equivalents NRC´s has?
What are NRC´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NRC/financial-strength
https://api.csimarket.com/api/v1/companies/NRC/fundamentals
https://api.csimarket.com/api/v1/companies/NRC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
NRC Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 8.5 %
Y / Y Cash & cash equivalent Change 63.41 %
Quick Ratio MRQ 0.09
NRC's Total Ranking # 3695
Seq. Current Liabilities Change 19.49 %
Seq. Cash & cash equivalent Change 8.99 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 31
Healthcare Sector # 845
Overall Market # 3695


Quick Ratio Statistics
High Average Low
2.25 0.68 0.01
(Mar 31 2021)   (Jun 30 2024)




Financial Statements
Nrc Health's Current Liabilities $ 42 Millions Visit NRC's Balance sheet
Nrc Health's Cash & cash equivalent $ 4 Millions Visit NRC's Balance sheet
Source of NRC's Sales Visit NRC's Sales by Geography


Cumulative Nrc Health's Quick Ratio

NRC's Quick Ratio for the trailling 12 Months

NRC Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 2.59 %
Y / Y Cash & cash equivalent TTM Growth -4.14 %
Quick Ratio TTM 0.09
Total Ranking TTM # 3334
Seq. Current Liabilities TTM Growth 2.21 %
Seq. Cash & cash equivalent TTM Growth 11.5 %


On the trailing twelve months basis NRC Cash & cash equivalent soared by 63.41 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Nrc Health's Quick Ratio to 0.09, Quick Ratio remained below NRC average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 36 other companies have achieved higher Quick Ratio than Nrc Health. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2897 to 4156.

Explain Quick Ratio?
How much Cash & cash equivalents NRC´s has?
What are NRC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 37
Healthcare Sector # 913
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
1.4 0.66 0.06
(Jun 30 2015)   (Dec 31 2024)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Laboratories Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Fortrea Holdings Inc   0.22 $ 220.600  Millions$ 983.300  Millions
Charles River Laboratories International inc   0.18 $ 200.381  Millions$ 1,089.258  Millions
Labcorp Holdings Inc   0.09 $ 261.800  Millions$ 2,819.600  Millions
Nrc Health  0.09 $ 3.626  Millions$ 41.845  Millions

Date modified: 2026-11-06T12:52:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.